{"response":{"meta":{"hits":35,"time":85,"offset":0},"docs":[{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/12\/11\/business\/11reuters-newedge-socgen-commodities.html","snippet":"Societe Generale's senior base metals trader, <PERSON>Mike Turek</PERSON>, <PERSON>Natasha Flora</PERSON>, energy trader, left bank <LOCATION>New York</LOCATION> <DATE>Thursday</DATE>, part wider retrenchment French bank's takeover <ORGANIZATION>Newedge</ORGANIZATION>, sources told <ORGANIZATION>Reuters</ORGANIZATION>.","lead_paragraph":"Societe Generale's senior base metals trader, <PERSON>Mike Turek</PERSON>, <PERSON>Natasha Flora</PERSON>, energy trader, left bank <LOCATION>New York</LOCATION> <DATE>Thursday</DATE>, part wider retrenchment French bank's takeover <ORGANIZATION>Newedge</ORGANIZATION>, sources told <ORGANIZATION>Reuters</ORGANIZATION>.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"<ORGANIZATION>Newedge Metal</ORGANIZATION>, Energy Traders Leave SocGen Cuts Headcount","print_headline":"<ORGANIZATION>Newedge Metal</ORGANIZATION>, Energy Traders Leave SocGen Cuts Headcount"},"keywords":[],"pub_date":"2014-12-11T17:24:06Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"548a19e17988102fcc1300ea","word_count":"333"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/11\/28\/business\/28reuters-merck-consumers.html","snippet":"<ORGANIZATION>Merck KGaA</ORGANIZATION> aims to keep hold of its consumer healthcare unit, it said on <DATE>Friday</DATE>, pledging to develop a business that is expected to generate <DATE>2014</DATE> sales of <MONEY>$1 billion 0.63 billion pounds</MONEY> for the German drugs and chemicals company.","lead_paragraph":"<ORGANIZATION>Merck KGaA</ORGANIZATION> aims to keep hold of its consumer healthcare unit, it said on <DATE>Friday</DATE>, pledging to develop a business that is expected to generate <DATE>2014</DATE> sales of <MONEY>$1 billion 0.63 billion pounds</MONEY> for the German drugs and chemicals company.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"<LOCATION>Germany</LOCATION>'s Merck Aims to Grow, Not Sell <MONEY>$1 Billion</MONEY> Consumer Health Arm","print_headline":"<LOCATION>Germany</LOCATION>'s Merck Aims to Grow, Not Sell <MONEY>$1 Billion</MONEY> Consumer Health Arm"},"keywords":[],"pub_date":"2014-11-28T09:24:55Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"5478867679881006dca8c3c1","word_count":"375"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/11\/04\/business\/04reuters-stocks-investment-founders-insight.html","snippet":"For good stock market bets, top investors bothered details corporate profits:, pick companies run founders.","lead_paragraph":"For good stock market bets, top investors bothered details corporate profits:, pick companies run founders.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"Insight-Top Investors Stay Loyal Big Name Corporate Founders","print_headline":"Insight-Top Investors Stay Loyal Big Name Corporate Founders"},"keywords":[],"pub_date":"2014-11-04T15:50:16Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"54593c6a79881027068435e0","word_count":"1004"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/10\/24\/business\/24reuters-unipharm-m-a-exclusive.html","snippet":"Over-the-counter drugmaker Unipharm is up for sale and has hired advisory firm <PERSON>Houlihan Lokey</PERSON> to explore a deal that could value it at around <MONEY>$500 million 310.83 million pounds</MONEY>, three sources familiar with the matter told <ORGANIZATION>Reuters</ORGANIZATION>.","lead_paragraph":"Over-the-counter drugmaker Unipharm is up for sale and has hired advisory firm <PERSON>Houlihan Lokey</PERSON> to explore a deal that could value it at around <MONEY>$500 million 310.83 million pounds</MONEY>, three sources familiar with the matter told <ORGANIZATION>Reuters</ORGANIZATION>.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"Exclusive-Unipharm Hires <PERSON>Houlihan Lokey</PERSON> to Explore <MONEY>$500 Million</MONEY> Sale - Sources","print_headline":"Exclusive-Unipharm Hires <PERSON>Houlihan Lokey</PERSON> to Explore <MONEY>$500 Million</MONEY> Sale - Sources"},"keywords":[],"pub_date":"2014-10-24T14:04:20Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"544a9545798810574ee7c4c7","word_count":"563"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/10\/20\/business\/20reuters-sigma-tau-m-a-alfa.html","snippet":"Italian drugmaker Sigma-Tau advanced talks sell part Italian operations domestic peer <PERSON>Alfa Wassermann</PERSON> create over-the-counter OTC powerhouse, sources familiar situation.","lead_paragraph":"Italian drugmaker Sigma-Tau advanced talks sell part Italian operations domestic peer <PERSON>Alfa Wassermann</PERSON> create over-the-counter OTC powerhouse, sources familiar situation.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"Sigma-Tau, <PERSON>Alfa Wassermann</PERSON> Talks Combine Italian Operations- Sources","print_headline":"Sigma-Tau, <PERSON>Alfa Wassermann</PERSON> Talks Combine Italian Operations- Sources"},"keywords":[],"pub_date":"2014-10-20T15:47:17Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"54456766798810347c1a833f","word_count":"653"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/10\/15\/business\/15reuters-clearing-derivatives-rules.html","snippet":"Clearing houses make trading derivatives safer spell recover crisis needing taxpayer bailouts, rules global regulators <DATE>Wednesday</DATE>.","lead_paragraph":"Clearing houses make trading derivatives safer spell recover crisis needing taxpayer bailouts, rules global regulators <DATE>Wednesday</DATE>.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"New Rules Stop Clearers Becoming 'Too Big Fail'","print_headline":"New Rules Stop Clearers Becoming 'Too Big Fail'"},"keywords":[],"pub_date":"2014-10-15T12:27:02Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"543ea18579881001751bf4a4","word_count":"401"},{"web_url":"http:\/\/parenting.blogs.nytimes.com\/2014\/10\/08\/an-over-the-counter-at-home-conception-aid\/","snippet":"Women exploring conception aids option: The <ORGANIZATION>Stork OTC</ORGANIZATION>, over-the counter cervical cap designed collect sperm intercourse.","lead_paragraph":null,"abstract":"Women exploring conception aids option: The <ORGANIZATION>Stork OTC</ORGANIZATION>, over-the counter cervical cap designed collect sperm intercourse.","print_page":null,"blog":[],"source":"The New York Times","multimedia":[{"subtype":"wide","url":"images\/2014\/10\/08\/us\/motherlode-stork\/motherlode-stork-thumbWide.jpg","height":126,"width":190,"legacy":{"wide":"images\/2014\/10\/08\/us\/motherlode-stork\/motherlode-stork-thumbWide.jpg","wideheight":"126","widewidth":"190"},"type":"image"},{"subtype":"xlarge","url":"images\/2014\/10\/08\/us\/motherlode-stork\/motherlode-stork-articleLarge.jpg","height":265,"width":600,"legacy":{"xlargewidth":"600","xlarge":"images\/2014\/10\/08\/us\/motherlode-stork\/motherlode-stork-articleLarge.jpg","xlargeheight":"265"},"type":"image"},{"subtype":"thumbnail","url":"images\/2014\/10\/08\/us\/motherlode-stork\/motherlode-stork-thumbStandard.jpg","height":75,"width":75,"legacy":{"thumbnailheight":"75","thumbnail":"images\/2014\/10\/08\/us\/motherlode-stork\/motherlode-stork-thumbStandard.jpg","thumbnailwidth":"75"},"type":"image"}],"headline":{"main":"An Over-the Counter At-Home Conception Aid","kicker":"Motherlode"},"keywords":[{"value":"Artificial Insemination","name":"subject","rank":"1"},{"value":"Infertility","name":"subject","rank":"2"},{"value":"Parenting","name":"subject","rank":"3"},{"value":"Pregnancy Childbirth","name":"subject","rank":"4"},{"value":"Sperm","name":"subject","rank":"5"}],"pub_date":"2014-10-08T15:44:30Z","document_type":"blogpost","news_desk":"Styles","section_name":"<LOCATION>U.S.</LOCATION>","subsection_name":null,"byline":{"person":[{"organization":"","role":"reported","rank":1,"firstname":"Kj","lastname":"DELL'ANTONIA"}],"original":"By KJ.DELL'ANTONIA"},"type_of_material":"Blog","_id":"5435946b798810520e354ade","word_count":"274"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/10\/08\/business\/08reuters-novartis-moves.html","snippet":"Swiss drugmaker <ORGANIZATION>Novartis AG</ORGANIZATION> members executive committee leave company completion transactions <ORGANIZATION>GlaxoSmithKline Eli Lilly</ORGANIZATION> divest units.","lead_paragraph":"Swiss drugmaker <ORGANIZATION>Novartis AG</ORGANIZATION> members executive committee leave company completion transactions <ORGANIZATION>GlaxoSmithKline Eli Lilly</ORGANIZATION> divest units.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"Novartis Says Three Executives Leave After <ORGANIZATION>GSK</ORGANIZATION>, <PERSON>Lilly</PERSON> Deals","print_headline":"Novartis Says Three Executives Leave After <ORGANIZATION>GSK</ORGANIZATION>, <PERSON>Lilly</PERSON> Deals"},"keywords":[],"pub_date":"2014-10-08T01:34:56Z","document_type":"article","news_desk":"None","section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"5434cd8c79881017f2d284d9","word_count":"244"},{"web_url":"http:\/\/dealbook.nytimes.com\/2014\/09\/15\/greed-continues-to-fuel-penny-stock-frauds\/","snippet":"Fraud market penny stocks continues unabated, criminal cases filed week show, <PERSON>Peter J. Henning</PERSON> writes White Collar Watch column.","lead_paragraph":null,"abstract":"Fraud market penny stocks continues unabated, criminal cases filed week show, <PERSON>Peter J. Henning</PERSON> writes White Collar Watch column.","print_page":null,"blog":[],"source":"The New York Times","multimedia":[{"width":190,"url":"images\/2014\/09\/15\/business\/dealbook\/dbpix-wolf\/dbpix-wolf-thumbWide.jpg","height":126,"subtype":"wide","legacy":{"wide":"images\/2014\/09\/15\/business\/dealbook\/dbpix-wolf\/dbpix-wolf-thumbWide.jpg","wideheight":"126","widewidth":"190"},"type":"image"},{"width":600,"url":"images\/2014\/09\/15\/business\/dealbook\/dbpix-wolf\/dbpix-wolf-articleLarge.jpg","height":400,"subtype":"xlarge","legacy":{"xlargewidth":"600","xlarge":"images\/2014\/09\/15\/business\/dealbook\/dbpix-wolf\/dbpix-wolf-articleLarge.jpg","xlargeheight":"400"},"type":"image"},{"width":75,"url":"images\/2014\/09\/15\/business\/dealbook\/dbpix-wolf\/dbpix-wolf-thumbStandard.jpg","height":75,"subtype":"thumbnail","legacy":{"thumbnailheight":"75","thumbnail":"images\/2014\/09\/15\/business\/dealbook\/dbpix-wolf\/dbpix-wolf-thumbStandard.jpg","thumbnailwidth":"75"},"type":"image"}],"headline":{"main":"Greed Continues Fuel Penny Stock Frauds","kicker":"DealBook"},"keywords":[{"rank":"1","name":"organizations","value":"Cynk Technology Corp"},{"rank":"1","name":"subject","value":"Frauds Swindling"},{"rank":"2","name":"subject","value":"Regulation Deregulation Industry"},{"rank":"3","name":"subject","value":"Securities Commodities Violations"}],"pub_date":"2014-09-15T12:03:39Z","document_type":"blogpost","news_desk":"Business","section_name":"Business Day","subsection_name":"Dealbook","byline":{"person":[{"firstname":"Peter","middlename":"J.","lastname":"HENNING","rank":1,"role":"reported","organization":""}],"original":"By <PERSON>PETER J. HENNING</PERSON>"},"type_of_material":"Blog","_id":"54170e9d79881018c378ee16","word_count":"1077"},{"web_url":"http:\/\/www.nytimes.com\/reuters\/2014\/09\/11\/business\/11reuters-financial-regulations-swaps.html","snippet":"Tensions growing regional regulators proposal collateral requirements make costly Asian companies trade European banks off-exchange derivatives -- complex financial products...","lead_paragraph":"Tensions growing regional regulators proposal collateral requirements make costly Asian companies trade European banks off-exchange derivatives -- complex financial products hedge price swings underlying assets ranging interest rates commodities.","abstract":null,"print_page":null,"blog":[],"source":"Reuters","multimedia":[],"headline":{"main":"<ORGANIZATION>EU</ORGANIZATION>'s OTC Derivatives Proposals Threaten Asian Regulatory Clash","print_headline":"<ORGANIZATION>EU</ORGANIZATION>'s OTC Derivatives Proposals Threaten Asian Regulatory Clash"},"keywords":[],"pub_date":"2014-09-11T07:49:11Z","document_type":"article","news_desk":null,"section_name":"Business Day","subsection_name":null,"byline":{"person":[],"original":"By REUTERS","organization":"REUTERS"},"type_of_material":"News","_id":"54118cd379881060c5af945d","word_count":"1140"}]},"status":"OK","copyright":"Copyright 2013 The <ORGANIZATION>New York Times Company</ORGANIZATION>.  All Rights Reserved."}